Literature DB >> 16732219

Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study.

G Tikellis1, L D Robman, P Dimitrov, C Nicolas, C A McCarty, R H Guymer.   

Abstract

AIMS: To determine the risk of age-related macular degeneration (AMD) progression posed by the presence of each early AMD characteristic.
METHODS: A prospective cohort study of 254 participants aged 50 years and older, all with early AMD features at their baseline visit followed for an average of 7 years. Stereoscopic colour fundus photographs were graded for early AMD features using the International Classification System. AMD status was stratified into six exclusive levels along a continuum of disease severity according to drusen type, pigmentary abnormalities, or late AMD. Progression was assessed according to three definitions: a change between or within a severity level, or by side by side grading.
RESULTS: The progression rate of early AMD ranged between 3.4 and 4.67% per annum depending upon the definition used. In total, 15 (6%) cases progressed from early AMD to the late complication of AMD. After controlling for age and smoking, cases with soft indistinct drusen at baseline were at a greater risk of progressing from early to late AMD than were cases without this characteristic (OR=3.72, 95%CI 1.20-11.54; P=0.02).
CONCLUSION: Our proposed definitions of AMD progression give rates that are consistent with current knowledge of progression and its determinants. Each early AMD characteristic conveys its own risk of progression to an eye, with soft indistinct drusen carrying the greater risk. An international consensus on what defines AMD progression would greatly help the research community when trying to assess the importance of new risk factors and the effectiveness of novel interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732219     DOI: 10.1038/sj.eye.6702151

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

Authors:  G Silvestri; M A Williams; C McAuley; K Oakes; E Sillery; D C Henderson; S Ferguson; V Silvestri; K A Muldrew
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

Review 2.  Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.

Authors:  Jessica N Cooke Bailey; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

3.  Heritability of Choroidal Thickness in the Amish.

Authors:  Rebecca J Sardell; Muneeswar G Nittala; Larry D Adams; Reneé A Laux; Jessica N Cooke Bailey; Denise Fuzzell; Sarada Fuzzell; Lori Reinhart-Mercer; Laura J Caywood; Violet Horst; Tine Mackay; Debbie Dana; SriniVas R Sadda; William K Scott; Dwight Stambolian; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Ophthalmology       Date:  2016-10-19       Impact factor: 12.079

4.  Retinoid analogs and polyphenols as potential therapeutics for age-related macular degeneration.

Authors:  Tanu Parmar; Joseph T Ortega; Beata Jastrzebska
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

Review 5.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

6.  Loss of melanoregulin (MREG) enhances cathepsin-D secretion by the retinal pigment epithelium.

Authors:  Laura S Frost; Vanda S Lopes; Frank P Stefano; Alvina Bragin; David S Williams; Claire H Mitchell; Kathleen Boesze-Battaglia
Journal:  Vis Neurosci       Date:  2013-04-23       Impact factor: 3.241

7.  ASSOCIATION OF PLASMA ω-3 FATTY ACIDS WITH EARLY AGE-RELATED MACULAR DEGENERATION IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS.

Authors:  Amy B Karger; Weihua Guan; Sarah O Nomura; Natalie L Weir; Barbara E K Klein; Gregory L Burke; W Craig Johnson; Michael Y Tsai
Journal:  Retina       Date:  2022-07-01       Impact factor: 3.975

8.  AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration.

Authors:  Muneeswar G Nittala; Yeunjoo E Song; Rebecca Sardell; Larry D Adams; Samuel Pan; Swetha B Velaga; Violet Horst; Debra Dana; Laura Caywood; Renee Laux; Denise Fuzzell; Sarada Fuzzell; William K Scott; Jessica N Cooke Bailey; Robert P Igo; Jonathan Haines; Margaret A Pericak-Vance; SriniVas R Sadda; Dwight Stambolian
Journal:  Retina       Date:  2019-08       Impact factor: 3.975

9.  Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study.

Authors:  Catherine A McCarty; Adam Dowrick; James Cameron; Barry McGrath; Luba D Robman; Peter Dimitrov; Gabriella Tikellis; Caroline Nicolas; John McNeil; Robyn Guymer
Journal:  BMC Ophthalmol       Date:  2008-12-22       Impact factor: 2.209

10.  Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).

Authors:  Robyn H Guymer; Peter N Dimitrov; Mary Varsamidis; Lyndell L Lim; Paul N Baird; Algis J Vingrys; Luba Robman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.